Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status.

Conor D TweedAngela M CrookRodney DawsonAndreas H DiaconTimothy D McHughCarl M MendelSarah K MeredithLerato MohapiMichael E MurphyAndrew J NunnPatrick P J PhillipsKasha P SinghMelvin SpigelmanStephen H Gillespie

Published in: BMC pulmonary medicine (2019)

HIV-positive patients receiving standard TB therapy in the REMoxTB study were at greater risk of adverse events during treatment but cure rates were similar when compared to a matched sample of HIV-negative patients.

Keyphrases

hiv positive
antiretroviral therapy
men who have sex with men
pulmonary tuberculosis
mycobacterium tuberculosis
south africa
human immunodeficiency virus
hiv infected
hiv testing
hepatitis c virus
hiv aids
end stage renal disease
ejection fraction
oxidative stress
prognostic factors
stem cells
oxide nanoparticles